We are live on ! Find out more
CPA

Cowen Prime Advisors Portfolio holdings

AUM $290M
1-Year Est. Return 57.8%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+57.8%
3 Year Est. Return
+115.57%
5 Year Est. Return
+253.93%
10 Year Est. Return
+968.63%
AUM
$219M
AUM Growth
+$25.5M
Cap. Flow
+$9.82M
Cap. Flow %
4.49%
Top 10 Hldgs %
55.88%
Holding
183
New
20
Increased
41
Reduced
28
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 32.11%
2 Healthcare 22.21%
3 Communication Services 18.51%
4 Materials 5.09%
5 Financials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
26
Starbucks
SBUX
$123B
$2.14M 0.98%
24,385
+3,835
+19% +$327K
KRNT icon
27
Kornit Digital
KRNT
$718M
$2.1M 0.96%
61,244
+4,650
+8% +$154K
EPD icon
28
Enterprise Products Partners
EPD
$84.3B
$1.97M 0.9%
70,080
LDOS icon
29
Leidos
LDOS
$17.7B
$1.66M 0.76%
17,000
-25,735
-60% -$2.27M
MSFT icon
30
Microsoft
MSFT
$3.81T
$1.64M 0.75%
10,425
-1,300
-11% -$191K
MTSI icon
31
MACOM Technology Solutions
MTSI
$20.3B
$1.61M 0.74%
60,658
+2,400
+4% +$57.3K
JPM icon
32
JPMorgan Chase
JPM
$951B
$1.58M 0.72%
11,329
-750
-6% -$96.2K
PTC icon
33
PTC
PTC
$17.1B
$1.52M 0.69%
20,250
+150
+0.7% +$10.7K
HTGM
34
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1.5M 0.69%
11,877
+11,321
+2,036% +$1.53M
DDD icon
35
3D Systems Corp
DDD
$545M
$1.33M 0.61%
152,300
+5,600
+4% +$48.6K
CVX icon
36
Chevron
CVX
$396B
$1.31M 0.6%
10,900
CSBR icon
37
Champions Oncology
CSBR
$68.5M
$1.28M 0.58%
+153,500
New +$948K
RDFN
38
DELISTED
Redfin
RDFN
$1.01M 0.46%
47,800
WY icon
39
Weyerhaeuser
WY
$17B
$977K 0.45%
32,350
TDAY
40
USA Today Co
TDAY
$931M
$966K 0.44%
151,400
+900
+0.6% +$6.6K
NRC icon
41
NRC Health Common Stock
NRC
$483M
$923K 0.42%
14,000
TEVA icon
42
Teva Pharmaceuticals
TEVA
$42.5B
$797K 0.36%
81,294
-860
-1% -$7.68K
NVEC icon
43
NVE Corp
NVEC
$488M
$795K 0.36%
11,137
+1,122
+11% +$73.1K
UAL icon
44
United Airlines
UAL
$35.9B
$785K 0.36%
8,910
-15,340
-63% -$1.38M
CEVA icon
45
CEVA Inc
CEVA
$764M
$747K 0.34%
27,721
+750
+3% +$20.5K
DOW icon
46
Dow Inc
DOW
$22B
$742K 0.34%
13,549
GSIT icon
47
GSI Technology
GSIT
$219M
$726K 0.33%
102,373
+13,616
+15% +$103K
NEOG icon
48
Neogen
NEOG
$2.54B
$704K 0.32%
21,580
-420
-2% -$13.8K
IBM icon
49
IBM
IBM
$222B
$654K 0.3%
5,107
+178
+4% +$23.1K
EGOV
50
DELISTED
NIC Inc
EGOV
$637K 0.29%
28,500
-1,200
-4% -$26.3K

Similar funds

Cowen Prime Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cowen Prime Advisors held 183 positions worth $219M, up 13% from $193M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Cowen Prime Advisors deployed $9.82M of net new capital in Q4 2019, opening 20 new positions and adding to 41 existing holdings. Its largest new stake was Champions Oncology: 153,500 shares worth $1.28M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 35% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Vonage Holdings Corporation, an estimated $2.71M trimmed.

  • Cowen Prime Advisors's largest Q4 2019 buy was Champions Oncology: 153,500 shares worth $1.28M.
  • Cowen Prime Advisors added most to Inovalon Holdings, Inc. Class A Common Stock in Q4 2019, an estimated $3.35M increase.
  • Cowen Prime Advisors's biggest Q4 2019 reduction was Vonage Holdings Corporation, cutting an estimated $2.71M.
  • Cowen Prime Advisors fully exited Genomic Health, Inc. in Q4 2019, selling an estimated $136K.
  • Cowen Prime Advisors's ten largest holdings make up 56% of its $219M portfolio in Q4 2019.
  • Cowen Prime Advisors opened 20 new positions and closed 3 in Q4 2019.
  • Cowen Prime Advisors's portfolio value rose 13% quarter-over-quarter to $219M.

Based on Cowen Prime Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.